TY - JOUR
T1 - Sleep and gynecological cancer outcomes
T2 - opportunities to improve quality of life and survival
AU - Zhao, Caroline
AU - Grubbs, Allison
AU - Barber, Emma L.
N1 - Funding Information:
Funding ELB is supported by NICHD (K12 HD050121-12), the NIA (P30AG059988-01A1), and the GOG Foundation.
Publisher Copyright:
©
PY - 2022/5/1
Y1 - 2022/5/1
N2 - Sleep is important for immune function, metabolic function and physical repair. Sleep is more commonly disrupted in women compared with men and is disrupted by surgery, chemotherapy, and cancer itself, making gynecological oncology patients at higher risk of insomnia and sleep disruption. Insomnia and sleep disruption are linked to increased pain, poorer quality of life, depression, and anxiety which can all negatively affect patient outcomes. A number of environmental, behavioral, and pharmacological interventions have been investigated to improve patient sleep and aid in the recovery process. It is vital to understand and address patient sleep quality in order to give patients the highest quality care and improve outcomes.
AB - Sleep is important for immune function, metabolic function and physical repair. Sleep is more commonly disrupted in women compared with men and is disrupted by surgery, chemotherapy, and cancer itself, making gynecological oncology patients at higher risk of insomnia and sleep disruption. Insomnia and sleep disruption are linked to increased pain, poorer quality of life, depression, and anxiety which can all negatively affect patient outcomes. A number of environmental, behavioral, and pharmacological interventions have been investigated to improve patient sleep and aid in the recovery process. It is vital to understand and address patient sleep quality in order to give patients the highest quality care and improve outcomes.
KW - Gynecologic Surgical Procedures
KW - Ovarian Cancer
KW - Postoperative Period
KW - Surgical Oncology
KW - Uterine Cancer
UR - http://www.scopus.com/inward/record.url?scp=85127619925&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85127619925&partnerID=8YFLogxK
U2 - 10.1136/ijgc-2022-003404
DO - 10.1136/ijgc-2022-003404
M3 - Review article
C2 - 35331996
AN - SCOPUS:85127619925
VL - 32
SP - 669
EP - 675
JO - International Journal of Gynecological Cancer
JF - International Journal of Gynecological Cancer
SN - 1048-891X
IS - 5
ER -
